18 results on '"Borriello, C."'
Search Results
2. The role of the built environment in dementia: evolution and adaptation of an innovative care model through the SARS-CoV-2 pandemic
- Author
-
Ferraguzzi, G, Zanetti, M, Mazzola, P, Sandrini, M, Sanvito, F, Gagliardo, R, Colaianni, A, Borriello, C, Cereda, D, Ferraguzzi G., Zanetti M., Mazzola P., Sandrini M., Sanvito F., Gagliardo R., Colaianni A., Borriello C., Cereda D., Ferraguzzi, G, Zanetti, M, Mazzola, P, Sandrini, M, Sanvito, F, Gagliardo, R, Colaianni, A, Borriello, C, Cereda, D, Ferraguzzi G., Zanetti M., Mazzola P., Sandrini M., Sanvito F., Gagliardo R., Colaianni A., Borriello C., and Cereda D.
- Abstract
Introduction: The first Alzheimers village in Italy rises in Monza named “Il Paese Ritrovato”, an innovative long-term care facility dedicated to individuals with mild-to-moderate Alzheimers disease or other Dementias. The total area is 3, 360 m2 and it hosts up to 64 guests divided into 8 apartments (single rooms and private bathrooms). The village includes buildings with highly recognizable features thanks to the careful selection of colors and finishes with classic, almost stereotypical, but familiar and reassuring lines that limit adequately furnished spaces. Every space is designed to stimulate cognitive functions and provide a good quality of life for residents. Methods: The retrospective cohort study involved 60 subjects. Variables collected from June 2018 to December 2020 included demographic data, cognitive and functional statuses, comorbidities, engagement in activities through the Engagement Social Index, and psychoactive medication use. Follow-up was performed every 6 months from admission until the Tcovid (starting covid Time) period. Outcomes included any significant changes due to isolation compared with the pre-pandemic period. Results: The study population had a mean age of 82.5 years (76.7% female), with a predominant diagnosis of AD (65%). Assessment at Tcovid showed rather different data than those recorded in the first 18 months with accelerated worsening of MMSE and CDR scales, increased prescription of antipsychotics (+5%), antidepressants (+11.7%, p=0.045) and benzodiazepines (+1.7%), and increased number of falls delineating the worsening of functional status accelerated by the pandemic. Limitations of the study include observational design and small sample size. Conclusion: The pandemic resulted in an abrupt reorganization of the care model with an orientation predominantly toward the health needs by disrupting the use of shared spaces and any opportunity for cognitive stimulation. This showed how psychosocial activity and appropriate study
- Published
- 2023
3. Balancing Benefits and Harms of COVID-19 Vaccines: Lessons from the Ongoing Mass Vaccination Campaign in Lombardy, Italy
- Author
-
Corrao, G, Rea, F, Franchi, M, Cereda, D, Barone, A, Borriello, C, Della Valle, G, Ercolanoni, M, Jara, J, Preziosi, G, Maffeo, M, Mazziotta, F, Pierini, E, Lecis, F, Sanchirico, P, Vignali, F, Leoni, O, Fortino, I, Galli, M, Pavesi, G, Bertolaso, G, Corrao G., Rea F., Franchi M., Cereda D., Barone A., Borriello C. R., Della Valle G. P., Ercolanoni M., Jara J., Preziosi G., Maffeo M., Mazziotta F., Pierini E., Lecis F., Sanchirico P., Vignali F., Leoni O., Fortino I., Galli M., Pavesi G., Bertolaso G., Corrao, G, Rea, F, Franchi, M, Cereda, D, Barone, A, Borriello, C, Della Valle, G, Ercolanoni, M, Jara, J, Preziosi, G, Maffeo, M, Mazziotta, F, Pierini, E, Lecis, F, Sanchirico, P, Vignali, F, Leoni, O, Fortino, I, Galli, M, Pavesi, G, Bertolaso, G, Corrao G., Rea F., Franchi M., Cereda D., Barone A., Borriello C. R., Della Valle G. P., Ercolanoni M., Jara J., Preziosi G., Maffeo M., Mazziotta F., Pierini E., Lecis F., Sanchirico P., Vignali F., Leoni O., Fortino I., Galli M., Pavesi G., and Bertolaso G.
- Abstract
Background. Limited evidence exists on the balance between the benefits and harms of the COVID-19 vaccines. The aim of this study is to compare the benefits and safety of mRNA-based (Pfizer-BioNTech and Moderna) and adenovirus-vectored (Oxford-AstraZeneca) vaccines in subpopulations defined by age and sex. Methods. All citizens who are newly vaccinated from 27 December 2020 to 3 May 2021 are matched to unvaccinated controls according to age, sex, and vaccination date. Study outcomes include the events that are expected to be avoided by vaccination (i.e., hospitalization and death from COVID-19) and those that might be increased after vaccine inoculation (i.e., venous thromboembolism). The incidence rate ratios (IRR) of vaccinated and unvaccinated citizens are separately estimated within strata of sex, age category and vaccine type. When suitable, number needed to treat (NNT) and number needed to harm (NNH) are calculated to evaluate the balance between the benefits and harm of vaccines within each sex and age category. Results. In total, 2,351,883 citizens are included because they received at least one dose of vaccine (755,557 Oxford-AstraZeneca and 1,596,326 Pfizer/Moderna). A reduced incidence of COVID-19-related outcomes is observed with a lowered incidence rate ranging from 55% to 89% and NNT values ranging from 296 to 3977. Evidence of an augmented incidence of harm-related outcomes is observed only for women aged <50 years within 28 days after Oxford-AstraZeneca (being the corresponding adjusted IRR of 2.4, 95% CI 1.1–5.6, and NNH value of 23,207, 95% CI 10,274–89,707). Conclusions. A favourable balance between benefits and harms is observed in the current study, even among younger women who received Oxford-AstraZeneca.
- Published
- 2022
4. Vulnerability Predictors of Post-Vaccine SARS-CoV-2 Infection and Disease—Empirical Evidence from a Large Population-Based Italian Platform
- Author
-
Corrao, G, Franchi, M, Cereda, D, Bortolan, F, Leoni, O, Borriello, C, Della Valle, P, Tirani, M, Pavesi, G, Barone, A, Ercolanoni, M, Jara, J, Galli, M, Bertolaso, G, Corrao G., Franchi M., Cereda D., Bortolan F., Leoni O., Borriello C. R., Della Valle P. G., Tirani M., Pavesi G., Barone A., Ercolanoni M., Jara J., Galli M., Bertolaso G., Corrao, G, Franchi, M, Cereda, D, Bortolan, F, Leoni, O, Borriello, C, Della Valle, P, Tirani, M, Pavesi, G, Barone, A, Ercolanoni, M, Jara, J, Galli, M, Bertolaso, G, Corrao G., Franchi M., Cereda D., Bortolan F., Leoni O., Borriello C. R., Della Valle P. G., Tirani M., Pavesi G., Barone A., Ercolanoni M., Jara J., Galli M., and Bertolaso G.
- Abstract
We aimed to identify individual features associated with increased risk of post-vaccine SARS-CoV-2 infection and severe COVID-19 illness. We performed a nested case–control study based on 5,350,295 citizens from Lombardy, Italy, aged ≥ 12 years who received a complete anti-COVID-19 vaccination from 17 January 2021 to 31 July 2021, and followed from 14 days after vaccine completion to 11 November 2021. Overall, 17,996 infections and 3023 severe illness cases occurred. For each case, controls were 1:1 (infection cases) or 1:10 (severe illness cases) matched for municipality of residence and date of vaccination completion. The association between selected predictors (sex, age, previous occurrence of SARS-CoV-2 infection, type of vaccine received, number of previous contacts with the Regional Health Service (RHS), and the presence of 59 diseases) and outcomes was assessed by using multivariable conditional logistic regression models. Sex, age, previous SARS-CoV-2 infection, type of vaccine and number of contacts with the RHS were associated with the risk of infection and severe illness. Moreover, higher odds of infection and severe illness were significantly associated with 14 and 34 diseases, respectively, among those investigated. These results can be helpful to clinicians and policy makers for prioritizing interventions.
- Published
- 2022
5. Protective action of natural and induced immunization against the occurrence of delta or alpha variants of SARS-CoV-2 infection: a test-negative case-control study
- Author
-
Corrao, G, Franchi, M, Rea, F, Cereda, D, Barone, A, Borriello, C, Della Valle, P, Ercolanoni, M, Fortino, I, Jara, J, Leoni, O, Mazziotta, F, Pierini, E, Preziosi, G, Tirani, M, Galli, M, Bertolaso, G, Pavesi, G, Bortolan, F, Corrao G., Franchi M., Rea F., Cereda D., Barone A., Borriello C. R., Della Valle P. G., Ercolanoni M., Fortino I., Jara J., Leoni O., Mazziotta F., Pierini E., Preziosi G., Tirani M., Galli M., Bertolaso G., Pavesi G., Bortolan F., Corrao, G, Franchi, M, Rea, F, Cereda, D, Barone, A, Borriello, C, Della Valle, P, Ercolanoni, M, Fortino, I, Jara, J, Leoni, O, Mazziotta, F, Pierini, E, Preziosi, G, Tirani, M, Galli, M, Bertolaso, G, Pavesi, G, Bortolan, F, Corrao G., Franchi M., Rea F., Cereda D., Barone A., Borriello C. R., Della Valle P. G., Ercolanoni M., Fortino I., Jara J., Leoni O., Mazziotta F., Pierini E., Preziosi G., Tirani M., Galli M., Bertolaso G., Pavesi G., and Bortolan F.
- Abstract
Background: The evolution of SARS-CoV-2 has led to the emergence of several new variants, and few data are available on the impact of vaccination on SARS-CoV-2 variants. We aimed to assess the association between natural (previous infection) and induced (partial or complete vaccination) exposure to SARS-CoV-2 and the onset of new infection supported by the delta variant, and of comparing it with that supported by alpha. Methods: We performed a test-negative case-control study, by linking population-based registries of confirmed diagnoses of infection with SARS-CoV-2, vaccinations against Covid-19 and healthcare utilization databases of the Italian Lombardy Region. Four hundred ninety-six persons who between 27 December 2020 and 16 July 2021 had an infection by the delta variant were 1:1 matched with citizens affected by alphavariant and 1:10 matched with persons who had a negative molecular test, according to gender, age and date of molecular ascertainment. We used a conditional logistic regression for estimating relative risk reduction of either variants associated with natural and/or induced immunization and corresponding 95% confidence interval (CI). Results: Previous infection was associated with 91% (95% CI 85% to 95%) reduced relative risk of reinfection, without evidence of significant differences between delta and alpha cases (p=0.547). Significant lower vaccinal protection against delta than alpha variant infection was observed with reduced relative risk associated with partial vaccination respectively of 29% (7% to 45%), and 62% (48% to 71%) (p=0.001), and with complete vaccination respectively of 75% (66% to 82%) and 90% (85% to 94%) (p=0.003). Conclusions: Lower protection towards infections caused by the delta variant with respect to alpha variant was noticed, even after the completion of the vaccination cycle. This finding would support efforts to maximize both vaccine uptake with two doses and fulfilment with individual protection measures, especially
- Published
- 2022
6. Persistence of protection against SARS-CoV-2 clinical outcomes up to 9 months since vaccine completion: a retrospective observational analysis in Lombardy, Italy
- Author
-
Corrao, G, Franchi, M, Cereda, D, Bortolan, F, Zoli, A, Leoni, O, Borriello, C, Valle, G, Tirani, M, Pavesi, G, Barone, A, Ercolanoni, M, Jara, J, Galli, M, Bertolaso, G, Mancia, G, Corrao, Giovanni, Franchi, Matteo, Cereda, Danilo, Bortolan, Francesco, Zoli, Alberto, Leoni, Olivia, Borriello, Catia Rosanna, Valle, Giulia Petra Della, Tirani, Marcello, Pavesi, Giovanni, Barone, Antonio, Ercolanoni, Michele, Jara, Jose, Galli, Massimo, Bertolaso, Guido, Mancia, Giuseppe, Corrao, G, Franchi, M, Cereda, D, Bortolan, F, Zoli, A, Leoni, O, Borriello, C, Valle, G, Tirani, M, Pavesi, G, Barone, A, Ercolanoni, M, Jara, J, Galli, M, Bertolaso, G, Mancia, G, Corrao, Giovanni, Franchi, Matteo, Cereda, Danilo, Bortolan, Francesco, Zoli, Alberto, Leoni, Olivia, Borriello, Catia Rosanna, Valle, Giulia Petra Della, Tirani, Marcello, Pavesi, Giovanni, Barone, Antonio, Ercolanoni, Michele, Jara, Jose, Galli, Massimo, Bertolaso, Guido, and Mancia, Giuseppe
- Abstract
Background: Scarce information is available on the duration of the protective effect of COVID-19 vaccination against the risk of SARS-CoV-2 infection and its severe clinical consequences. We investigated the effect of time since vaccine completion on the SARS-CoV-2 infection and its severe forms. Methods: In this retrospective observational analysis using the vaccination campaign integrated platform of the Italian region of Lombardy, 5 351 085 individuals aged 12 years or older who received complete vaccination from Jan 17 to July 31, 2021, were followed up from 14 days after vaccine completion until Oct 20, 2021. Changes over time in outcome rates (ie, SARS-CoV-2 infection and severe illness among vaccinated individuals) were analysed with age-period-cohort models. Trends in vaccine effectiveness (ie, outcomes comparison in vaccinated and unvaccinated individuals) were also measured. Findings: Overall, 14 140 infections and 2450 severe illnesses were documented, corresponding to incidence rates of 6·7 (95% CI 6·6–6·8) and 1·2 (1·1–1·2) cases per 10 000 person-months, respectively. From the first to the ninth month since vaccine completion, rates increased from 4·6 to 10·2 infections, and from 1·0 to 1·7 severe illnesses every 10 000 person-months. These figures correspond to relative reduction of vaccine effectiveness of 54·9% (95% CI 48·3–60·6) for infection and of 40·0% (16·2–57·0) for severe illness. The increasing infection rate was greater for individuals aged 60 years or older who received adenovirus-vectored vaccines (from 4·0 to 23·5 cases every 10 000 person-months). The increasing severe illness rates were similar for individuals receiving mRNA-based vaccines (from 1·1 to 1·5 every 10 000 person-months) and adenovirus-vectored vaccines (from 0·5 to 0·9 every 10 000 person-months). Interpretation: Although the risk of infection after vaccination, and even more of severe illness, remains low, the gradual increase in clinical outcomes related to SARS-CoV-2 i
- Published
- 2022
7. Persistence of protection against SARS-CoV-2 clinical outcomes up to 9 months since vaccine completion: a retrospective observational analysis in Lombardy, Italy
- Author
-
Giovanni Corrao, Matteo Franchi, Danilo Cereda, Francesco Bortolan, Alberto Zoli, Olivia Leoni, Catia Rosanna Borriello, Giulia Petra Della Valle, Marcello Tirani, Giovanni Pavesi, Antonio Barone, Michele Ercolanoni, Jose Jara, Massimo Galli, Guido Bertolaso, Giuseppe Mancia, Corrao, G, Franchi, M, Cereda, D, Bortolan, F, Zoli, A, Leoni, O, Borriello, C, Valle, G, Tirani, M, Pavesi, G, Barone, A, Ercolanoni, M, Jara, J, Galli, M, Bertolaso, G, and Mancia, G
- Subjects
COVID-19 Vaccines ,Infectious Diseases ,SARS-CoV-2 ,COVID-19 ,Humans ,persistence ,Articles ,COVID-19 vaccine ,effectivene - Abstract
Background: Scarce information is available on the duration of the protective effect of COVID-19 vaccination against the risk of SARS-CoV-2 infection and its severe clinical consequences. We investigated the effect of time since vaccine completion on the SARS-CoV-2 infection and its severe forms. Methods: In this retrospective observational analysis using the vaccination campaign integrated platform of the Italian region of Lombardy, 5 351 085 individuals aged 12 years or older who received complete vaccination from Jan 17 to July 31, 2021, were followed up from 14 days after vaccine completion until Oct 20, 2021. Changes over time in outcome rates (ie, SARS-CoV-2 infection and severe illness among vaccinated individuals) were analysed with age-period-cohort models. Trends in vaccine effectiveness (ie, outcomes comparison in vaccinated and unvaccinated individuals) were also measured. Findings: Overall, 14 140 infections and 2450 severe illnesses were documented, corresponding to incidence rates of 6·7 (95% CI 6·6–6·8) and 1·2 (1·1–1·2) cases per 10 000 person-months, respectively. From the first to the ninth month since vaccine completion, rates increased from 4·6 to 10·2 infections, and from 1·0 to 1·7 severe illnesses every 10 000 person-months. These figures correspond to relative reduction of vaccine effectiveness of 54·9% (95% CI 48·3–60·6) for infection and of 40·0% (16·2–57·0) for severe illness. The increasing infection rate was greater for individuals aged 60 years or older who received adenovirus-vectored vaccines (from 4·0 to 23·5 cases every 10 000 person-months). The increasing severe illness rates were similar for individuals receiving mRNA-based vaccines (from 1·1 to 1·5 every 10 000 person-months) and adenovirus-vectored vaccines (from 0·5 to 0·9 every 10 000 person-months). Interpretation: Although the risk of infection after vaccination, and even more of severe illness, remains low, the gradual increase in clinical outcomes related to SARS-CoV-2 infection suggests that the booster campaign should be accelerated and that social and individual protection measures against COVID-19 spread should not be abandoned. Funding: None.
- Published
- 2022
8. Vulnerability Predictors of Post-Vaccine SARS-CoV-2 Infection and Disease-Empirical Evidence from a Large Population-Based Italian Platform
- Author
-
Giovanni Corrao, Matteo Franchi, Danilo Cereda, Francesco Bortolan, Olivia Leoni, Catia Rosanna Borriello, Petra Giulia Della Valle, Marcello Tirani, Giovanni Pavesi, Antonio Barone, Michele Ercolanoni, Jose Jara, Massimo Galli, Guido Bertolaso, Corrao, G, Franchi, M, Cereda, D, Bortolan, F, Leoni, O, Borriello, C, Della Valle, P, Tirani, M, Pavesi, G, Barone, A, Ercolanoni, M, Jara, J, Galli, M, and Bertolaso, G
- Subjects
Pharmacology ,Infectious Diseases ,SARS-CoV-2 ,vaccine ,vulnerability ,Drug Discovery ,Immunology ,COVID-19 ,vaccines ,predictors ,predictor ,Pharmacology (medical) - Abstract
We aimed to identify individual features associated with increased risk of post-vaccine SARS-CoV-2 infection and severe COVID-19 illness. We performed a nested case–control study based on 5,350,295 citizens from Lombardy, Italy, aged ≥ 12 years who received a complete anti-COVID-19 vaccination from 17 January 2021 to 31 July 2021, and followed from 14 days after vaccine completion to 11 November 2021. Overall, 17,996 infections and 3023 severe illness cases occurred. For each case, controls were 1:1 (infection cases) or 1:10 (severe illness cases) matched for municipality of residence and date of vaccination completion. The association between selected predictors (sex, age, previous occurrence of SARS-CoV-2 infection, type of vaccine received, number of previous contacts with the Regional Health Service (RHS), and the presence of 59 diseases) and outcomes was assessed by using multivariable conditional logistic regression models. Sex, age, previous SARS-CoV-2 infection, type of vaccine and number of contacts with the RHS were associated with the risk of infection and severe illness. Moreover, higher odds of infection and severe illness were significantly associated with 14 and 34 diseases, respectively, among those investigated. These results can be helpful to clinicians and policy makers for prioritizing interventions.
- Published
- 2022
9. Balancing Benefits and Harms of COVID-19 Vaccines: Lessons from the Ongoing Mass Vaccination Campaign in Lombardy, Italy
- Author
-
Giovanni Corrao, Federico Rea, Matteo Franchi, Danilo Cereda, Antonio Barone, Catia Rosanna Borriello, Giulia Petra Della Valle, Michele Ercolanoni, Jose Jara, Giuseppe Preziosi, Manuel Maffeo, Francesco Mazziotta, Elisabetta Pierini, Francesco Lecis, Pierfrancesco Sanchirico, Francesco Vignali, Olivia Leoni, Ida Fortino, Massimo Galli, Giovanni Pavesi, Guido Bertolaso, Corrao, G, Rea, F, Franchi, M, Cereda, D, Barone, A, Borriello, C, Della Valle, G, Ercolanoni, M, Jara, J, Preziosi, G, Maffeo, M, Mazziotta, F, Pierini, E, Lecis, F, Sanchirico, P, Vignali, F, Leoni, O, Fortino, I, Galli, M, Pavesi, G, and Bertolaso, G
- Subjects
Pharmacology ,Infectious Diseases ,venous thromboembolism ,Drug Discovery ,Immunology ,COVID-19 ,Pharmacology (medical) ,healthcare utilization database ,effectiveness ,effectivene - Abstract
Background. Limited evidence exists on the balance between the benefits and harms of the COVID-19 vaccines. The aim of this study is to compare the benefits and safety of mRNA-based (Pfizer-BioNTech and Moderna) and adenovirus-vectored (Oxford-AstraZeneca) vaccines in subpopulations defined by age and sex. Methods. All citizens who are newly vaccinated from 27 December 2020 to 3 May 2021 are matched to unvaccinated controls according to age, sex, and vaccination date. Study outcomes include the events that are expected to be avoided by vaccination (i.e., hospitalization and death from COVID-19) and those that might be increased after vaccine inoculation (i.e., venous thromboembolism). The incidence rate ratios (IRR) of vaccinated and unvaccinated citizens are separately estimated within strata of sex, age category and vaccine type. When suitable, number needed to treat (NNT) and number needed to harm (NNH) are calculated to evaluate the balance between the benefits and harm of vaccines within each sex and age category. Results. In total, 2,351,883 citizens are included because they received at least one dose of vaccine (755,557 Oxford-AstraZeneca and 1,596,326 Pfizer/Moderna). A reduced incidence of COVID-19-related outcomes is observed with a lowered incidence rate ranging from 55% to 89% and NNT values ranging from 296 to 3977. Evidence of an augmented incidence of harm-related outcomes is observed only for women aged
- Published
- 2022
10. Protective action of natural and induced immunization against the occurrence of delta or alpha variants of SARS-CoV-2 infection: a test-negative case-control study
- Author
-
Giovanni Corrao, Matteo Franchi, Federico Rea, Danilo Cereda, Antonio Barone, Catia Rosanna Borriello, Petra Giulia Della Valle, Michele Ercolanoni, Ida Fortino, Jose Jara, Olivia Leoni, Francesco Mazziotta, Elisabetta Pierini, Giuseppe Preziosi, Marcello Tirani, Massimo Galli, Guido Bertolaso, Giovanni Pavesi, Francesco Bortolan, Corrao, G, Franchi, M, Rea, F, Cereda, D, Barone, A, Borriello, C, Della Valle, P, Ercolanoni, M, Fortino, I, Jara, J, Leoni, O, Mazziotta, F, Pierini, E, Preziosi, G, Tirani, M, Galli, M, Bertolaso, G, Pavesi, G, and Bortolan, F
- Subjects
SARS-CoV-2 variants ,Public health ,COVID-19 Vaccines ,SARS-CoV-2 ,Case-Control Studies ,Vaccination ,COVID-19 ,Humans ,Medicine ,Immunization ,General Medicine ,SARS-CoV-2 variant - Abstract
Abstract Background The evolution of SARS-CoV-2 has led to the emergence of several new variants, and few data are available on the impact of vaccination on SARS-CoV-2 variants. We aimed to assess the association between natural (previous infection) and induced (partial or complete vaccination) exposure to SARS-CoV-2 and the onset of new infection supported by the delta variant, and of comparing it with that supported by alpha. Methods We performed a test-negative case-control study, by linking population-based registries of confirmed diagnoses of infection with SARS-CoV-2, vaccinations against Covid-19 and healthcare utilization databases of the Italian Lombardy Region. Four hundred ninety-six persons who between 27 December 2020 and 16 July 2021 had an infection by the delta variant were 1:1 matched with citizens affected by alphavariant and 1:10 matched with persons who had a negative molecular test, according to gender, age and date of molecular ascertainment. We used a conditional logistic regression for estimating relative risk reduction of either variants associated with natural and/or induced immunization and corresponding 95% confidence interval (CI). Results Previous infection was associated with 91% (95% CI 85% to 95%) reduced relative risk of reinfection, without evidence of significant differences between delta and alpha cases (p=0.547). Significant lower vaccinal protection against delta than alpha variant infection was observed with reduced relative risk associated with partial vaccination respectively of 29% (7% to 45%), and 62% (48% to 71%) (p=0.001), and with complete vaccination respectively of 75% (66% to 82%) and 90% (85% to 94%) (p=0.003). Conclusions Lower protection towards infections caused by the delta variant with respect to alpha variant was noticed, even after the completion of the vaccination cycle. This finding would support efforts to maximize both vaccine uptake with two doses and fulfilment with individual protection measures, especially as the delta variant is rampant worldwide presently.
- Published
- 2022
11. Regole tecniche e legittimità nell'applicazione del regolamento da parte degli arbitri
- Author
-
GUIDO CLEMENTE DI SAN LUCA, G. Aiello, M. Angelone, L. Attolico, G. Bacosi, A. Berti Suman, A. Blandini, F. Borriello, C. Buonauro, R. Cangiano, M. Cardito, L. Caso, E. Chiacchio, G. Chinè, A. Citarella, S. Civale, P. Clarizia, G. Clemente di San Luca, C. Contessa, A. Cusimano, P. Del Vecchio, F. Di Cagno, M. Del Zotto, L. Di Nella, A. Fanizza, F. Ferraro, S. Frascà, M. Gallavotti, A.M. Gambino, L. Giacomardo, A. Giordano, P. Grasso, G. Greco, E. Indraccolo, S. La Porta, A. Lepore, P. Leozappa, M. Magaldi, U. Maiello, E. Mangialardi, A.M. Marzocco, A. Marzoli, G. Mastrandrea, R. Mastroianni, F. Mite, F. Monaco, A. Montone, D. Morgante, G. Nava, V. Nunziata, S. Palazzi, A. Panichella, G. Panzironi, R. Pessi, R. Picaro, L. Ruggiero Malagnini, M. Salzano, P. Sandulli, M. Sangiorgio, M. Sanino, L. Santoro, M. Sferrazza, S. Sica, C. Sica, M.R. Spasiano, R. Stincardini, G. Terracciano, M. Tita, J. Tognon, M.L. Torsello, A. Vitale, L. Vizzino, M. Zaccheo, G. Zuccaro, A. Dimitri Zumbo, P. Del Vecchio, L. Giacomardo, M. Sferrazza, R. Stincardini, and CLEMENTE DI SAN LUCA, Guido
- Published
- 2022
12. Photo-Responsivity Improvement of Photo-Mobile Polymers Actuators Based on a Novel LCs/Azobenzene Copolymer and ZnO Nanoparticles Network
- Author
-
Domenico Sagnelli, Marcella Calabrese, Olga Kaczmarczyk, Massimo Rippa, Ambra Vestri, Valentina Marchesano, Kristoffer Kortsen, Valentina Cuzzucoli Crucitti, Fulvia Villani, Fausta Loffredo, Carmela Borriello, Giuseppe Nenna, Mariacristina Cocca, Veronica Ambrogi, Katarzyna Matczyszyn, Francesco Simoni, Lucia Petti, Sagnelli, D., Calabrese, M., Kaczmarczyk, O., Rippa, M., Vestri, A., Marchesano, V., Kortsen, K., Crucitti, V. C., Villani, F., Loffredo, F., Borriello, C., Nenna, G., Cocca, M., Ambrogi, V., Matczyszyn, K., Simoni, F., and Petti, L.
- Subjects
azobenzene monomers ,ZnO nanoparticles ,General Chemical Engineering ,02 engineering and technology ,Photo-mobile material ,actuators ,010402 general chemistry ,021001 nanoscience & nanotechnology ,photo-mobile materials ,smart materials ,liquid crystals ,01 natural sciences ,Article ,0104 chemical sciences ,Chemistry ,Liquid crystal ,Smart material ,Actuator ,Azobenzene monomer ,General Materials Science ,0210 nano-technology ,QD1-999 - Abstract
The efficiency of photomobile polymers (PMP) in the conversion of light into mechanical work plays a fundamental role in achieving cutting-edge innovation in the development of novel applications ranging from energy harvesting to sensor approaches. Because of their photochromic properties, azobenzene monomers have been shown to be an efficient material for the preparation of PMPs with appropriate photoresponsivity. Upon integration of the azobenzene molecules as moieties into a polymer, they act as an engine, allowing fast movements of up to 50 Hz. In this work we show a promising approach for integrating ZnO nanoparticles into a liquid crystalline polymer network. The addition of such nanoparticles allows the trapping of incoming light, which acts as diffusive points in the polymer matrix. We characterized the achieved nanocomposite material in terms of thermomechanical and optical properties and finally demonstrated that the doped PMP was better performing that the undoped PMP film.
- Published
- 2021
13. Silver-Doped Reduced Graphene Oxide/PANI-DBSA-PLA Composite 3D-Printed Supercapacitors.
- Author
-
Cirillo C, Iuliano M, Scarpa D, Iovane P, Borriello C, Portofino S, Galvagno S, and Sarno M
- Abstract
This study presents a novel approach to the development of high-performance supercapacitors through 3D printing technology. We synthesized a composite material consisting of silver-doped reduced graphene oxide (rGO) and dodecylbenzenesulfonic acid (DBSA)-doped polyaniline (PANI), which was further blended with polylactic acid (PLA) for additive manufacturing. The composite was extruded into filaments and printed into circular disc electrodes using fused deposition modeling (FDM). These electrodes were assembled into symmetric supercapacitor devices with a solid-state electrolyte. Electrochemical characterization, including cyclic voltammetry (CV) and galvanostatic charge-discharge (GCD) tests, demonstrated considerable mass-specific capacitance values of 136.2 F/g and 133 F/g at 20 mV/s and 1 A/g, respectively. The devices showed excellent stability, retaining 91% of their initial capacitance after 5000 cycles. The incorporation of silver nanoparticles enhanced the conductivity of rGO, while PANI-DBSA improved electrochemical stability and performance. This study highlights the potential of combining advanced materials with 3D printing to optimize energy storage devices, offering a significant advancement over traditional manufacturing methods.
- Published
- 2024
- Full Text
- View/download PDF
14. Reinforcing Efficiency of Recycled Carbon Fiber PLA Filament Suitable for Additive Manufacturing.
- Author
-
Tammaro L, Martone A, Palmieri B, Borriello C, Portofino S, Iovane P, Cilento F, Giordano M, and Galvagno S
- Abstract
The use of 3D printing technology for manufacturing new products based on sustainable materials enables one to take advantage of secondary raw materials derived from recycling. This work investigates the structural performances of 3D printing composite filaments based on polylactic acid (PLA), as a matrix, reinforced by recycled carbon fiber (rCF). Carbon fibers were recovered from industrial scraps by a patented thermal process and used to produce thermoplastic composite filaments for additive manufacturing without any additional treatment and additives. The influence of the recovered carbon fiber (rCF) content on the thermal properties, mechanical properties and microstructure of the composites was studied in the range of 3-20 wt%. The recorded TGA curves exhibited a one-stage weight loss within the temperature range 290-380 °C for all samples and the residual rCF content was in good agreement with the theoretical fiber loading. The Young modulus of the extruded filaments strongly increased below a critical content (5 wt%), while at higher content the improvement was reduced. An increase in the storage modulus of 54% compared to neat PLA 3D printed sample resulted in a printed specimen with a higher rCF content. SEM images highlighted a strong rCF prevailing alignment in the direction of the extrusion flow, creating almost unidirectional reinforcement inside the filament. These findings suggest that homogeneous composite filaments reinforced with well-dispersed recycled CF without additional chemical modification and additives are suitable materials for additive manufacturing. The effect of rCF topological distribution within the material on the mechanical performances has been discussed, highlighting that the isolated fibers could efficiently transfer loads with respect to the percolated 3D network and have been correlated with the microstructure.
- Published
- 2024
- Full Text
- View/download PDF
15. Self-assembled monolayers of reduced graphene oxide for robust 3D-printed supercapacitors.
- Author
-
Scarpa D, Iuliano M, Cirillo C, Iovane P, Borriello C, Portofino S, Ponticorvo E, Galvagno S, and Sarno M
- Abstract
Herein, additive manufacturing, which is extremely promising in different sectors, has been adopted in the electrical energy storage field to fabricate efficient materials for supercapacitor applications. In particular, Al
2 O3 -, steel-, and Cu-based microparticles have been used for the realization of 3D self-assembling materials covered with reduced graphene oxide to be processed through additive manufacturing. Functionalization of the particles with amino groups and a subsequent "self-assembly" step with graphene oxide, which was contextually partially reduced to rGO, was carried out. To further improve the electrical conductivity and AM processability, the composites were coated with a polyaniline-dodecylbenzene sulfonic acid complex and further blended with PLA. Afterward, they were extruded in the form of filaments, printed through the fused deposition modeling technique, and assembled into symmetrical solid-state devices. Electrochemical tests showed a maximum mass capacitance of 163 F/g, a maximum energy density of 15 Wh/Kg at 10 A/g, as well as good durability (85% capacitance retention within 5000 cycles) proving the effectiveness of the preparation and the efficiency of the as-manufactured composites., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
16. Vaccination Open Day: A Cross-Sectional Study on the 2023 Experience in Lombardy Region, Italy.
- Author
-
Perrone PM, Scarioni S, Astorri E, Marrocu C, Tiwana N, Letzgus M, Borriello C, and Castaldi S
- Subjects
- Italy, Humans, Cross-Sectional Studies, Female, Male, Influenza Vaccines administration & dosage, Adult, Middle Aged, Child, Child, Preschool, Pneumococcal Vaccines administration & dosage, Pregnancy, Aged, COVID-19 prevention & control, Vaccination statistics & numerical data, COVID-19 Vaccines administration & dosage
- Abstract
Background: Vaccination is a highly effective tool for controlling infectious diseases, particularly in populations at high risk of contagion due to clinical conditions or occupational exposure, such as healthcare workers. The purpose of this study is to present the open day event that marked the beginning of the influenza and anti-COVID-19 vaccination campaign in the Lombardy region and to describe the experience of an Istituto di Ricovero e Cura a Carattere Scientifico in Milan., Methods: During the vaccination open day, eligible individuals received free vaccinations for influenza, COVID-19, pneumococcal disease, and shingles, as provided by the Lombardy Agenzia per la Tutela della Salute. In celebration of the centenary of the Università degli Studi di Milano, the Fondazione Ca'Granda Ospedale Policlinico, a contracted hospital of the university, created a special electronic diary for a total of 150 individuals, equally divided between children aged 2-6, pregnant women, and university staff., Results: At the regional level, a total of 6634 influenza vaccines, 2055 anti-COVID-19 vaccines, 108 anti-pneumococcal vaccines, and 37 anti-zoster vaccines were administered. A total of 3134 (47.3%) influenza vaccines, 1151 (56%) anti-COVID-19 vaccines, and 77 (62%) anti-pneumococcal vaccines, were given to individuals aged 60-79. No differences were observed between the total number of male and female vaccinees (1017 and 1038, respectively), who received the anti-COVID-19 vaccine. At the Policlinico Foundation, out of 150 available booking slots, 154 vaccines were administered, including 117 influenza vaccines., Conclusions: The establishment of vaccine open days is a beneficial way to increase vaccine compliance. Co-administration of little-known vaccinations outside of healthcare settings could also be a useful tool.
- Published
- 2024
- Full Text
- View/download PDF
17. Tungsten disulfide nanotubes enhance flow-induced crystallization and radio-opacity of polylactide without adversely affecting in vitro toxicity.
- Author
-
Ramachandran K, Shao Z, Di Luccio T, Shen B, Bello EER, Tammaro L, Villani F, Loffredo F, Borriello C, Di Benedetto F, Magee E, McNally T, and Kornfield JA
- Subjects
- Crystallization, Sulfides, Tungsten Compounds, Nanotubes, Polyesters
- Abstract
Treatment of vascular disease, from peripheral ischemia to coronary heart disease (CHD), is poised for transformation with the introduction of transient implants designed to "scaffold" regeneration of blood vessels and ultimately leave nothing behind. Improved materials could expand the use of these devices. Here, we examine one of the leading polymers for bioresorbable scaffolds (BRS), polylactide (PLA), as the matrix of nanocomposites with tungsten disulfide (WS
2 ) nanotubes (WSNT), which may provide mechanical reinforcement and enhance radio-opacity. We evaluate in vitro cytotoxicity using vascular cells, flow-induced crystallization and radio-opacity of PLA-WSNT nanocomposites at low WSNT concentration. A small amount of WSNT (0.1 wt%) can effectively promote oriented crystallization of PLA without compromising molecular weight. And radio-opacity improves significantly: as little as 0.5 to 1 wt% WSNT doubles the radio-opacity of PLA-WSNT relative to PLA at 17 keV. The results suggest that a single component, WSNT, has the potential to increase the strength of BRS to enable thinner devices and increase radio-opacity to improve intraoperative visualization. The in vitro toxicity results indicate that PLA-WSNT nanocomposites are worthy of investigation in vivo. Although substantial further preclinical studies are needed, PLA-WSNT nanocomposites may provide a complement of material properties that may improve BRS and expand the range of lesions that can be treated using transient implants. STATEMENT OF SIGNIFICANCE: Bioresorbable Scaffolds (BRSs) support regeneration of arteries without permanent mechanical constraint. Poly-L-lactide (PLLA) is the structural material of the first approved BRS for coronary heart disease (ABSORB BVS), withdrawn due to adverse events in years 1-3. Here, we examine tungsten disulfide (WS2 ) nanotubes (WSNT) in PLA to address two contributors to early complications: (1) reinforce PLLA (enable thinner BRS), and (2) increase radiopacity (provide intraoperative visibility). For BRS, it is significant that WSNT disperse, remain dispersed, reduce friction and improve mechanical properties without additional chemicals or surface modifications. Like WS2 nanospheres, bare WSNT and PLA-WSNT nanocomposites show low cytotoxicity in vitro. PLA-WSNT show enhanced flow-induced crystallization relative to PLA, motivating future study of the processing behavior and strength of these materials., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2021 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF
18. Photo-Responsivity Improvement of Photo-Mobile Polymers Actuators Based on a Novel LCs/Azobenzene Copolymer and ZnO Nanoparticles Network.
- Author
-
Sagnelli D, Calabrese M, Kaczmarczyk O, Rippa M, Vestri A, Marchesano V, Kortsen K, Cuzzucoli Crucitti V, Villani F, Loffredo F, Borriello C, Nenna G, Cocca M, Ambrogi V, Matczyszyn K, Simoni F, and Petti L
- Abstract
The efficiency of photomobile polymers (PMP) in the conversion of light into mechanical work plays a fundamental role in achieving cutting-edge innovation in the development of novel applications ranging from energy harvesting to sensor approaches. Because of their photochromic properties, azobenzene monomers have been shown to be an efficient material for the preparation of PMPs with appropriate photoresponsivity. Upon integration of the azobenzene molecules as moieties into a polymer, they act as an engine, allowing fast movements of up to 50 Hz. In this work we show a promising approach for integrating ZnO nanoparticles into a liquid crystalline polymer network. The addition of such nanoparticles allows the trapping of incoming light, which acts as diffusive points in the polymer matrix. We characterized the achieved nanocomposite material in terms of thermomechanical and optical properties and finally demonstrated that the doped PMP was better performing that the undoped PMP film.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.